Light-activated Bioconjugates for Applications in Synthesis and Biosensing

点击翻译按钮获取中文摘要

This project will allow the Australian biotechnology industry to develop better diagnostic biosensors that are controlled using light, making them cheaper and faster than the current generation of electronically controlled biosensors. Improvements in the response time of biosensors can be a matter of life and death, for instance, during a surgical operation. The project will benefit the pharmaceutical industry as it will allow the making of so-called chiral drugs cheaper and safer but problems with the purity of chiral drugs have in the past caused serious side-effects such as in the tragic case of thalidomide.